Brings Delhi’s first-ever comprehensive preventive health solution called Smart Gene Plan ...
To drive further advancements in healthcare technology and foster transformative innovation in patient care...
The joint venture will help enable the Saudi Vision 2030 and several other national priority initiatives related to genomic testing and the growth of the Saudi Arabian biotech sector...
The joint venture will help enable the Saudi Vision 2030 and several other national priority initiatives related to genomic testing and the growth of the Saudi Arabian biotech sector...
DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into an agreement with JADBio to utilize its Automated Machine Learning (AutoML) Platform and Services for development of predictive models based on DiamiR's microRNA panels and other factors for risk assessment in Alzheimer's disease and Rett syndrome....
BioBank Japan, a hospital-based multi-institutional biobank that has collected DNA, serum and medical record information from ~260,000 patients affected by one of 51 pre-defined diseases, is now launching a new phase to accelerate precision medicine and health in Japan. In an address on May 24 in Tokyo, Professor Yoichiro Kamatani, a member of the Steering Committee at BioBank Japan, presented the new phase and future direction of this important biobank for the future health of Japan. In an inte...
The machine is set up at a cost of Rs 12 crore...
